Clinical Trials on Other Abortion in Canada
Total 324 results
-
Hoffmann-La RocheCompletedSchizophreniaGermany, France, Canada, Spain, Italy, Brazil, Argentina, United Kingdom
-
Centre for Addiction and Mental HealthCanadian Institutes of Health Research (CIHR)CompletedSchizophrenia | Schizoaffective Disorder | Schizophreniform Disorder | Major Depressive Disorder | Bipolar I Disorder | Bipolar II Disorder | Psychosis Not Otherwise Specified | Substance-Induced PsychosesCanada
-
Vanguard Research GroupOtsuka America PharmaceuticalCompleted
-
Stryker Trauma GmbHEnrolling by invitationAvascular Necrosis | Osteoarthritis Shoulder | Post-traumatic Arthrosis of Other Joints, Shoulder RegionUnited States, Canada, France, Switzerland
-
Novartis PharmaceuticalsTerminatedMelanoma | Ovarian Cancer | NSCLC | Other Solid TumorsItaly, Spain, Netherlands, France, Korea, Republic of, Switzerland, Germany, Japan, United States, Canada
-
Janssen-Cilag International NVCompletedSchizophreniaUkraine, Canada, Sweden, Czech Republic, Denmark, Thailand, Kazakhstan
-
AstraZenecaCompletedSchizophreniaUnited States, Bulgaria, Spain, Estonia, Hungary, Latvia, Finland, Canada, Germany, Italy, Lithuania, Australia
-
H. Lundbeck A/SCompletedSchizophreniaEstonia, Mexico, Russian Federation, Serbia, Ukraine, United States, Bulgaria, Canada, Czechia, Poland, Slovakia, Spain, Romania
-
Boehringer IngelheimCompletedSchizophreniaSpain, Korea, Republic of, United Kingdom, Taiwan, United States, Austria, Italy, Germany, Poland, Japan, Canada
-
AstraZenecaUniversity of North CarolinaCompletedMental Disorders | Psychotic Disorders | Schizophrenia | Mental HealthUnited States, Canada
-
Otsuka Pharmaceutical Europe LtdH. Lundbeck A/SUnknownSchizophreniaSpain, Italy, France, Germany
-
Otsuka Pharmaceutical Development & Commercialization...TerminatedSchizophrenia | Schizoaffective Disorder | Metabolic Syndrome | Bipolar I DisorderCanada
-
ACADIA Pharmaceuticals Inc.CompletedSchizophreniaUnited States, Russian Federation, Hungary, Bulgaria, Serbia, Ukraine, Lithuania, Canada, Czechia, Poland
-
Hoffmann-La RocheCompletedSchizophreniaGermany, Spain, Turkey, Canada, United States, Netherlands, Chile, Brazil, Taiwan, Poland, Ukraine, Slovakia, Lithuania, Latvia
-
Hoffmann-La RocheCompletedSchizophreniaGermany, Spain, Turkey, Canada, United States, Netherlands, Chile, Brazil, Taiwan, Poland, Ukraine, Slovakia, Lithuania, Latvia
-
Hoffmann-La RocheCompletedSchizophreniaUnited States, Poland, Hungary, Russian Federation, Germany, Austria, France, Brazil, Japan, Mexico
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedSchizophreniaUnited States, Bulgaria, Canada, France, Israel
-
ACADIA Pharmaceuticals Inc.CompletedSchizophreniaUnited States, Spain, Hungary, Bulgaria, Russian Federation, Serbia, Ukraine, Poland, Canada, Czechia
-
Ortho-McNeil Janssen Scientific Affairs, LLCTerminatedSchizophreniaUnited States, China, Colombia, Bulgaria, India, Malaysia, Russian Federation, Ukraine, Canada, Korea, Republic of, Brazil, Czech Republic
-
diaMentis Inc.Active, not recruitingSchizophrenia | Bipolar I DisorderUnited States, Australia, Canada
-
AstraZenecaCompletedSchizophreniaUnited States, Canada
-
Otsuka Pharmaceutical Development & Commercialization...CompletedSchizophreniaUnited States, India, Malaysia, Philippines, Romania, Russian Federation, Taiwan
-
Boehringer IngelheimTerminatedPsychotic DisordersUnited States, Canada, United Kingdom, China
-
Otsuka Pharmaceutical Development & Commercialization...TerminatedSchizophreniaUnited States
-
H. Lundbeck A/SCompletedSchizophreniaEstonia, Mexico, Poland, Serbia, Ukraine, United States, Bulgaria, Canada, Czechia, Finland, Romania, Russian Federation, Slovakia, Spain
-
Otsuka Pharmaceutical Development & Commercialization...Completed
-
ACADIA Pharmaceuticals Inc.Active, not recruitingSchizophreniaUkraine, Argentina, Bulgaria, Croatia, Czechia, Hungary, Italy, Lithuania, Poland, Russian Federation, Serbia, Spain, United States, Canada
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAcute SchizophreniaKorea, Republic of, United States, Serbia, Ukraine, Romania, Poland, Canada, Latvia, Japan
-
Boehringer IngelheimActive, not recruitingClinical Trial of Iclepertin Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-1)SchizophreniaSweden, Canada, Italy, Japan, United States, Turkey, Greece, Germany, China, New Zealand, Australia, Mexico, Philippines, Poland, Brazil, Colombia, Norway
-
SunovionCompletedSchizophrenia | Bipolar DisorderCanada, Serbia, Colombia, Czech Republic, India, Lithuania, Slovakia, Ukraine, France, Romania, South Africa, Russian Federation
-
Hoffmann-La RocheCompletedSchizophreniaUnited States, China, Italy, Bulgaria, Russian Federation, Japan, Czech Republic
-
BioCeryxUniversity of British Columbia; University College London Hospitals; Brugmann... and other collaboratorsUnknownTrisomy 21 and Other Fetal AneuploidyAustralia, United Kingdom, Spain, Canada, Belgium, Portugal
-
Hoffmann-La RocheCompletedSchizophreniaUnited States, Italy, China, Japan, Russian Federation, Bulgaria, Czech Republic
-
University of AlbertaCanadian Institutes of Health Research (CIHR)RecruitingHeart Failure | Cancer | Chronic Kidney Diseases | Cirrhosis, Liver | Primary Biliary Cholangitis | Digestive Diseases | Women Who Have Experienced a Cardiac Event | Post-Transplant | Other Chronic Physical ConditionCanada
-
Otsuka Pharmaceutical Development & Commercialization...CompletedSchizophreniaKorea, Republic of, United States, Philippines, Malaysia, Croatia, Serbia, Russian Federation, Ukraine, Romania, Puerto Rico, Colombia, Turkey, Poland, Taiwan, Canada, Latvia, Slovakia, Mexico, Japan
-
Janssen Research & Development, LLCCompletedSchizophreniaFrance, United States, China, Spain, Argentina, Mexico, Portugal, Bulgaria, Germany, Poland, Russian Federation, Ukraine, Japan, Greece, Taiwan, Korea, Republic of, Canada, Czech Republic, Brazil, Hungary, Austria, Sweden, Romania, Sl... and more
-
Otsuka Pharmaceutical Development & Commercialization...CompletedSchizophrenia | Major Depressive Disorder | Bipolar I DisorderUnited States
-
AstraZenecaCompletedSchizophrenia | Bipolar DisorderSpain
-
OctapharmaCompletedPrimary and Secondary Immunodeficiency and Other Conditions Requiring Regular Administration of Octagam 5% or 10% IVIGCanada, Austria, France, Spain, United Kingdom
-
Boehringer IngelheimRecruitingSchizophreniaKorea, Republic of, Canada, United States, Taiwan, United Kingdom, Chile, Serbia, Brazil, China, Colombia, Germany, Greece, Italy, Japan, Mexico, Norway, Poland, Sweden, Spain, Argentina, Croatia, France, Slovakia, Denmark, Malaysia, Czechia and more
-
Brigham and Women's HospitalNational Institute of Mental Health (NIMH); Yale University; OrygenRecruitingPsychosis | Remission | Conversion | Clinical High RiskUnited States, United Kingdom, Canada, Italy, Australia, Chile, China, Denmark, Germany, Hong Kong, Korea, Republic of, Singapore, Spain, Switzerland
-
Lawson Health Research InstituteImperial College London; Queen's University; Northern Ontario School of MedicineCompletedObesity | Schizophrenia | Schizoaffective Disorder | Insulin Resistance | Tardive DyskinesiaCanada, United Kingdom
-
Fundación Pública Andaluza para la gestión de la...Active, not recruitingIntellectual Disability | PsychosisSpain
-
Otsuka Pharmaceutical Development & Commercialization...Otsuka America PharmaceuticalCompletedSchizophrenia | Schizoaffective DisorderUnited States
-
Eli Lilly and CompanyCompletedSchizophrenia | Schizoaffective Disorder | Bipolar DisorderUnited States, Puerto Rico, Netherlands, Canada, Mexico
-
AbbVie (prior sponsor, Abbott)CompletedCognitive Deficits in SchizophreniaUnited States
-
IDEAYA BiosciencesRecruitingColorectal Cancer | Metastatic Uveal Melanoma | Cutaneous Melanoma | Other Solid TumorsUnited States, Australia, Canada
-
ApoPharmaTerminatedIron Overload | Sickle Cell Disease | Other AnemiasUnited States, United Kingdom, Egypt, Canada, Saudi Arabia
-
Solvay PharmaceuticalsWyeth is now a wholly owned subsidiary of Pfizer; H. Lundbeck A/SCompletedSchizophrenia and Schizoaffective DisorderHungary, United States, Argentina, Canada, Czech Republic, Estonia, France, Latvia, Lithuania
-
FORUM Pharmaceuticals IncSyneos Health; NeuroCog Trials, Inc.CompletedSchizophrenia | Impaired CognitionUnited States, Australia, Poland, Ukraine, Germany, Spain, Argentina, Serbia, Canada, Singapore, Russian Federation, Brazil, Mexico